Company Profile

Sphinx Pharmaceutical Corporation (AKA: Sphinx Biotechnologies Corporation)
Profile last edited on: 4/1/19      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1987
First Award
1987
Latest Award
1994
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4 University Place Box 52330
Durham, NC 27707
   (919) 489-0909
   N/A
   N/A
Location: Single
Congr. District: 01
County: Durham

Public Profile

With close ties to personnel involved in the in-house Sphinx Division of Eli Lilly, Sphinx Pharamcetical Corporation was a drug discovery company created to identify lead compounds that regulate the many isozymes of Protein Kinases. Unique in the application of patented technology that provided the accurate assay of membrane bound enzymes. As company grew, technology was applied to the study of phospholipases, prostaglandins and sphingomyelinases. Company was bought by Eli Lilly in in 1995

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1994 1 NIH $75,000
Project Title: Protein Kinase C Modulators from Marine Invertebrates
1992 1 NIH $50,000
Project Title: Cyclic AMP binding proteins and RAS function
1992 1 NIH $50,000
Project Title: Membrane bound RAS P21 regulation by gap and lipids
1988 1 NIH $50,000
Project Title: Reporter assays for tumor promoters
1987 1 NIH $50,000
Project Title: Protein Kinase C Therapeutic Developmental Tools

Key People / Management

  Lawrence M Ballas

  Stephen B Bocckino

  Palaniappan Kulanthaivel

  Carson R Loomis

  Men-Hwei Tsai

Company News

There are no news available.